Children's Healthcare of Atlanta - Egleston Hospital ( Site 0107)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)	Bacterial Infections and Mycoses, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Enterobacteriaceae Infections, Infections, Proteus infectious disease, bacterial infectious disease, central nervous system malformation, gram-negative bacterial infections, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy	Active, not recruiting	Phase 2	2025-02-07		NCT04980872

Clinical trials